Eli Lilly, Incyte, and CSL Receive EU Drug Recommendations
An expert panel of the European Medicines Agency endorsed six new medicines and 11 label expansions this week, benefiting drugmakers including Eli Lilly (LLY), Incyte (INCY), and CSL Limited (CSL). The approvals could boost investor confidence in these companies.
